Results 21 to 30 of about 14,670,208 (357)

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

open access: yesTherapeutic Drug Monitoring, 2021
When mycophenolic acid (MPA) was originally marketed for immunosuppressive therapy, fixed doses were recommended by the manufacturer. Awareness of the potential for a more personalized dosing has led to development of methods to estimate MPA area under ...
S. Bergan   +37 more
semanticscholar   +1 more source

Dried Blood Spots—A Platform for Therapeutic Drug Monitoring (TDM) and Drug/Disease Response Monitoring (DRM)

open access: yesEuropean journal of drug metabolism and pharmacokinetics, 2023
This review provides an overview on the current applications of dried blood spots (DBS) as matrices for therapeutic drug (TDM) and drug or disease response monitoring (DRM).
Nuraini Zailani, P. Ho
semanticscholar   +1 more source

Determination of Osimertinib, Aumolertinib, and Furmonertinib in Human Plasma for Therapeutic Drug Monitoring by UPLC-MS/MS

open access: yesMolecules, 2022
The third-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), osimertinib, aumolertinib, and furmonertinib represent a new treatment option for patients with EGFR p.Thr790 Met (T790 M)-mutated non-small cell lung cancer ...
Ying Li   +6 more
doaj   +1 more source

Expert consensus statement on therapeutic drug monitoring and individualization of linezolid

open access: yesFrontiers in Public Health, 2022
Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval.
B. Lin   +36 more
semanticscholar   +1 more source

Structure Analysis of the Interfering Substance N-methyl-2-phenylpropan-1-amine of Methamphetamine in Wastewater

open access: yesFayixue Zazhi, 2022
ObjectiveTo analyze the chemical structure of the interfering substance that affects the result of methamphetamine analysis in wastewater.MethodsA combination of GC-MS and liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) was
ZHANG Ting-ting   +4 more
doaj   +1 more source

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

open access: yesIntensive Care Medicine, 2020
This Position Paper aims to review and discuss the available data on therapeutic drug monitoring (TDM) of antibacterials, antifungals and antivirals in critically ill adult patients in the intensive care unit (ICU).
M. Abdul-Aziz   +15 more
semanticscholar   +1 more source

Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives.

open access: yesGastroenterology, 2022
Therapeutic drug monitoring (TDM) has emerged as a strategy for treatment optimization in inflammatory bowel diseases in order to maximise benefit and to reach more stringent, objective endpoints.
P. Irving, K. Gecse
semanticscholar   +1 more source

Microneedle Aptamer-Based Sensors for Continuous, Real-Time Therapeutic Drug Monitoring

open access: yesAnalytical Chemistry, 2022
The ability to continuously monitor the concentration of specific molecules in the body is a long-sought goal of biomedical research. For this purpose, interstitial fluid (ISF) was proposed as the ideal target biofluid because its composition can rapidly
Yao Wu   +16 more
semanticscholar   +1 more source

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2021
Importance Proactive therapeutic drug monitoring (TDM), defined as individualized drug dosing based on scheduled monitoring of serum drug levels, has been proposed as an alternative to standard therapy to maximize efficacy and safety of infliximab and ...
S. W. Syversen   +32 more
semanticscholar   +1 more source

Monitoring drug adherence [PDF]

open access: yesTransplantation Reviews, 2015
Medication nonadherence is prevalent in transplant recipients and is a major reason for graft loss. The present review discusses the measurement of adherence in transplant recipients and strategies to improve adherence. SOURCES REVIEWED: Since adherence research is not confined to transplant recipients, our literature review included studies relevant ...
Sarah R, Lieber   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy